CD133+ cells isolated from CRC cell populations have been shown to mimic properties of CRC cancer stem cells and CD44+ cells exhibit enhanced tumorigenicity and cell proliferation in CRC [35, 36]. The gene discussed is PROM1; the disease is cancer.